Page last updated: 2024-08-17

levodopa and Basal Ganglia Diseases

levodopa has been researched along with Basal Ganglia Diseases in 89 studies

Research

Studies (89)

Timeframe	Studies, this research(%)	All Research%
pre-1990	44 (49.44)	18.7374
1990's	21 (23.60)	18.2507
2000's	10 (11.24)	29.6817
2010's	12 (13.48)	24.3611
2020's	2 (2.25)	2.80

Authors

Authors	Studies
Jiang, W; Li, R; Lin, Y; Ma, L; Zhang, N	1
Attar, A; Fong, C; Lu, JQ	1
Bourgois, N; De Schlichting, E; Deffond, D; Durif, F; Ferrier, A; Jean, B; Marques, A; Mathais, S; Merlin, C; Valla, C; Vidal, T	1
Cestari, DM; Eichler, FS; Hunt, AL; Rapalino, O; Swoboda, KJ	1
Greene, P	1
Castelnovo, G; Colombier, L; Lippi, A; Renard, D	1
Iwata, A; Ohtomo, R; Tsuji, S	1
Brianti, R; Caffarra, P; Galuppo, L; Mammi, P	1
Jog, M; Kumar, N	1
Alp, R; Alp, SI; Ure, H	1
Tison, F	1
Artigas, CF; Espino Ibáñez, A; Masmiquel Comas, L; Nicolau Ramis, J; Rivera Irigoín, R	1
Gomis, P; Graftieaux, JP; Malinovsky, JM; Poivert, C; Scherpereel, B	1
Ballaz, S; Fuentes, A; Morales, I; Obeso, JA; Rodriguez, M	1
Lalla, R; Patil, TB; Verma, R	1
Angelini, L; Blau, N; Fernandez Alvarez, E; Garavaglia, B; Invernizzi, F; Nardocci, N; Pannacci, M; Sesta, M; Zorzi, G	1
Benecke, R; Classen, J; Grossmann, A; Kunesch, E; Wolters, A	1
Farsang, M; Kovács, T; Szirmai, I; Takáts, A	1
Burn, DJ; McKeith, IG; Molloy, S; O'Brien, JT	1
Le Rhun, E; Lebert, F	1
Caltagirone, C; Chiavalon, C; Fermi, E; Gasbarra, A; Mazzone, P; Peppe, A; Pierantozzi, M; Stanzione, P; Stefani, A	1
Bartholini, G; Lloyd, KG	1
Itoh, H	1
Hunter, KR	1
Marsden, CD	1
Luther, JS; Stoudemire, A	1
Tarsy, D	1
Mutani, R; Sechi, GP; Tanda, F	1
Barbeau, A	1
Hardie, RJ; Lees, AJ; Stern, GM	1
Farquhar, JW; Ledingham, JG; MacLeod, MD; Munro, JF	1
Hirayama, K; Yamada, T	1
Markova, ED; Shmidt, EV; Tkachev, RA	1
Goldman, JW; Haldeman, S; Hyde, J; Pribram, HF	1
Angelini, L; Broggi, G; Mainini, P; Moretti, G; Nardocci, N	1
Korczyn, AD; Kuritzky, A; Nisipeanu, P	1
Corey-Bloom, J; Galasko, D; Olichney, JM; Thal, LJ	1
Defer, GL; Degos, JD; Malapert, D; Remy, P; Ricolfi, F; Samson, Y	1
Strange, PG	1
Jimenez-Jimenez, J; Legarda, I; Obeso, JA; Vaamonde, J; Zubieta, JL	1
Bergmans, PL; Konings, CH; Kuiper, MA; Wolters, EC	1
Goldhammer, Y; Sadeh, M	1
Hesselink, JM	1
Cote, LJ; Richards, M; Stern, Y	1
Graybiel, AM	1
Keskin, S; Yurdakul, F	1
Bassi, A; Cicardi, MC; Loberti, M; Pierantozzi, M; Semprini, R; Stanzione, P; Traversa, R	1
Arutiunian, NA; Iakimovskiĭ, AF	1
Arai, H; Kobayashi, H; Nakagawa, T; Sasaki, H; Sekizawa, K	1
Arnold, G; Gasser, T; Künig, G; Oertel, WH; Pogarell, O; Schwarz, J; Tatsch, K	1
Bassi, A; Bernardi, G; Formisano, R; Peppe, A; Piccolino, M; Pierantozzi, M; Santilli, AM; Semprini, R; Stanzione, P	1
Ghaemi, M; Rudolf, J; Schmülling, S	1
Chin, S; Dhawan, V; Eidelberg, D; Fahn, S; Frucht, S	1
Bennett, NK; Campbell, JM; Davies, RW; Favor, G; Payne, AP; Russell, D; Stone, TW; Sutcliffe, RG	1
Baracchini, C; Burlina, AB; Burlina, AP; Carollo, C	1
Gerlach, J; Lühdorf, K	1
Bartholini, G	1
Drachman, DA; Stahl, S	1
Barkhatova, VP; Insarova, NG; Ivanova-Smolenskaia, IA; Markova, ED	1
Calne, DB; Eisler, T	1
Biswas, PN; Sarker, SK	1
Filion, M; Langelier, P; Larochelle, L; Poirier, L	1
Agnoli, A; Casacchia, M; Ruggieri, S	1
Hökendorf, H	1
Jörg, J	1
Goetz, CG; Klawans, HL; Nausieda, PA; Weiner, WJ	1
Kobayashi, T; Nakagawa, S; Nakano, T; Tsukakoshi, H; Yanagisawa, N	1
Girke, W; Xenakis, Ch	1
Chase, TN; Pelton, EW	1
Bengesser, G	1
Morocutti, A; Rizzo, PA	1
Marsden, CD; Pycock, C; Tarsy, D	1
Stimmel, GL	1
Dyck, PJ; Jaradeh, S	1
Ahlskog, JE; Fealey, RD; Low, PA; Sandroni, P	1
Bartholomé, K; Görke, W	1
Petelin, LS	1
Flauto, C; Groppetti, A; Parati, E; Parenti, M; Vescovi, A	1
Defazio, G; Ferrari, E; Lamberti, P; Lepore, V; Livrea, P	1
Cummings, JL; Wirshing, WC	1
Imai, H; Komiya, T; Narabayashi, H; Usui, S	1
Martí, MJ; Tolosa, E	1
Hoerning, E; Kaplan, PE; Sohn, DG	1
Grauel, A	1
Widhalm, S	1
Jankovic, J; Pettigrew, LC	1
Poirier, LJ	1
Parkes, D	1
Anagnoste, B; Battista, AF; Fuxe, K; Goldstein, M; Miyamoto, T	1

Reviews

21 review(s) available for levodopa and Basal Ganglia Diseases

Article	Year
Progressive Supranuclear Palsy, Corticobasal Degeneration, and Multiple System Atrophy. Continuum (Minneapolis, Minn.), 2019, Volume: 25, Issue:4 Topics: Aged; Basal Ganglia Diseases; Diagnosis, Differential; Dopamine Agents; Female; Humans; Levodopa; Male; Middle Aged; Multiple System Atrophy; Supranuclear Palsy, Progressive	2019
["Red flags": when to be alerted and how to explore?]. Revue neurologique, 2010, Volume: 166, Issue:10 Topics: Antiparkinson Agents; Basal Ganglia Diseases; Biomarkers; Diagnosis, Differential; Humans; Levodopa; Lewy Body Disease; Magnetic Resonance Imaging; Multiple System Atrophy; Parkinson Disease; Supranuclear Palsy, Progressive	2010
[Clinical features of corticobasal degeneration]. Ideggyogyaszati szemle, 2005, Jan-20, Volume: 58, Issue:1-2 Topics: Aged; Basal Ganglia; Basal Ganglia Diseases; Cerebral Cortex; Diagnosis, Differential; Dopamine Agents; Female; Humans; Levodopa; Magnetic Resonance Imaging; Nerve Degeneration; Neurodegenerative Diseases; Parkinson Disease	2005
[Treatment of dementia with Lewy bodies]. Revue neurologique, 2006, Volume: 162, Issue:1 Topics: Antiparkinson Agents; Antipsychotic Agents; Autonomic Nervous System Diseases; Basal Ganglia Diseases; Case Management; Cholinesterase Inhibitors; Combined Modality Therapy; Drug Resistance; Drug Therapy, Combination; Hallucinations; Humans; Levodopa; Lewy Body Disease; Mental Disorders; Mood Disorders; Nootropic Agents; Physical Therapy Modalities; Sleep Wake Disorders; Speech Therapy	2006
The potential of GABA-mimetics in the therapy of extrapyramidal disorders. Journal of neural transmission. Supplementum, 1980, Issue:16 Topics: Antipsychotic Agents; Basal Ganglia Diseases; Dopamine; gamma-Aminobutyric Acid; Humans; Levodopa; Neurons; Parasympathetic Nervous System; Receptors, Drug	1980
Drug-induced tardive dyskinesia. Current developments in psychopharmacology, 1981, Volume: 6 Topics: Aging; Antipsychotic Agents; Basal Ganglia Diseases; Diagnosis, Differential; Dyskinesia, Drug-Induced; Humans; Huntington Disease; Levodopa; Psychotic Disorders; Racial Groups; Sex Factors	1981
Movement disorders with neuroleptic drug treatment. The Psychiatric clinics of North America, 1984, Volume: 7, Issue:3 Topics: Acute Disease; Akathisia, Drug-Induced; Antipsychotic Agents; Basal Ganglia Diseases; Diagnosis, Differential; Dopamine; Dopamine Antagonists; Dyskinesia, Drug-Induced; Humans; Huntington Disease; Levodopa; Neuroleptic Malignant Syndrome; Parasympatholytics; Parkinson Disease, Secondary; Receptors, Dopamine; Time Factors; Tourette Syndrome	1984
[Dyskinesia (author's transl)]. No to shinkei = Brain and nerve, 1980, Volume: 32, Issue:11 Topics: Basal Ganglia Diseases; Dyskinesia, Drug-Induced; Humans; Hyperkinesis; Hypersensitivity, Delayed; Levodopa; Movement Disorders; Psychotropic Drugs	1980
The spectrum of diseases with diffuse Lewy bodies. Advances in neurology, 1995, Volume: 65 Topics: Age Factors; Alzheimer Disease; Basal Ganglia Diseases; Cerebral Cortex; Dementia; Humans; Levodopa; Lewy Bodies	1995
Dopamine receptors in the basal ganglia: relevance to Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 1993, Volume: 8, Issue:3 Topics: Basal Ganglia; Basal Ganglia Diseases; Brain; Clozapine; Dopamine Agents; Dopamine D2 Receptor Antagonists; Female; Haloperidol; Humans; Levodopa; Male; Neostriatum; Neural Pathways; Parkinson Disease; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride	1993
Basal ganglia: new therapeutic approaches to Parkinson's disease. Current biology : CB, 1996, Apr-01, Volume: 6, Issue:4 Topics: Animals; Basal Ganglia; Basal Ganglia Diseases; Humans; Levodopa; Nerve Growth Factors; Neurosurgery; Parkinson Disease; Tyrosine 3-Monooxygenase	1996
The AS/AGU rat: a spontaneous model of disruption and degeneration in the nigrostriatal dopaminergic system. Journal of anatomy, 2000, Volume: 196 ( Pt 4) Topics: Animals; Basal Ganglia Diseases; Disease Models, Animal; Dopamine; Genes, Recessive; Levodopa; Rats; Rats, Mutant Strains	2000
The pathogensis and medical treatment of extrapyramidal disease. The Medical clinics of North America, 1979, Volume: 63, Issue:4 Topics: Adult; Athetosis; Basal Ganglia Diseases; Caudate Nucleus; Chorea; Corpus Striatum; Dopamine; Dopamine Antagonists; Drug Administration Schedule; Dystonia; Female; gamma-Aminobutyric Acid; Glutamates; Haloperidol; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Tic Disorders	1979
Brain nervous mechanisms involved in the so-called extra pyramidal motor and psychomotor disturbances. Progress in neurobiology, 1975, Volume: 5, Issue:3 Topics: Animals; Athetosis; Basal Ganglia Diseases; Brain; Brain Stem; Cats; Corpus Striatum; Disease Models, Animal; Dopa Decarboxylase; Dopamine; Extrapyramidal Tracts; Globus Pallidus; Haplorhini; Homovanillic Acid; Humans; Levodopa; Monoamine Oxidase; Neural Pathways; Olivary Nucleus; Psychomotor Disorders; Red Nucleus; Tyrosine 3-Monooxygenase	1975
[Side-effects of L-dopa therapy]. Deutsche medizinische Wochenschrift (1946), 1975, Oct-17, Volume: 100, Issue:42 Topics: Arrhythmias, Cardiac; Basal Ganglia Diseases; Depression; Female; Gastrointestinal Diseases; Humans; Hypotension, Orthostatic; Levodopa; Male; Nausea; Parkinson Disease, Secondary; Psychoses, Substance-Induced; Sex Factors; Time Factors; Vomiting	1975
L-Dopa and the treatment of extrapyramidal disease. Advances in pharmacology and chemotherapy, 1975, Volume: 13 Topics: Adjuvants, Pharmaceutic; Animals; Basal Ganglia Diseases; Biodegradation, Environmental; Catecholamines; Dopamine; Humans; Levodopa; Mice; Parkinson Disease; Rats	1975
[Clinical problems of extrapyramidal diseases]. Klinicheskaia meditsina, 1990, Volume: 68, Issue:9 Topics: Basal Ganglia; Basal Ganglia Diseases; Dopamine; Humans; Levodopa	1990
Extrapyramidal syndromes in the elderly: diagnosis and management. Geriatrics, 1989, Volume: 44, Issue:2 Topics: Aged; Aged, 80 and over; Basal Ganglia Diseases; Humans; Levodopa	1989
Blepharospasm-oromandibular dystonia syndrome (Meige's syndrome): clinical aspects. Advances in neurology, 1988, Volume: 49 Topics: Basal Ganglia Diseases; Dyskinesia, Drug-Induced; Facial Muscles; Female; Humans; Levodopa; Meige Syndrome	1988
Nervous mechanisms involved in experimentally induced extrapyramidal disturbances. Confinia neurologica, 1974, Volume: 36, Issue:4-6 Topics: Animals; Basal Ganglia Diseases; Benztropine; Brain; Cats; Caudate Nucleus; Cerebellar Nuclei; Chlorpromazine; Corpus Striatum; Disease Models, Animal; Dopamine; Haloperidol; Haplorhini; Humans; Levodopa; Movement Disorders; Olivary Nucleus; Parkinson Disease; Putamen; Rats; Red Nucleus; Substantia Nigra; Thalamic Nuclei; Tremor	1974
Amantadine. Advances in drug research, 1974, Volume: 8 Topics: Acetylcholine; Amantadine; Animals; Antiviral Agents; Basal Ganglia Diseases; Behavior, Animal; Catecholamines; Chemical Phenomena; Chemistry; Dogs; Dopamine; Electroencephalography; Guinea Pigs; Haplorhini; Hemodynamics; Humans; Kinetics; Levodopa; Mice; Movement Disorders; Parasympatholytics; Parkinson Disease; Rabbits; Rats; Serotonin; Virus Diseases	1974

Trials

7 trial(s) available for levodopa and Basal Ganglia Diseases

Article	Year
The role of levodopa in the management of dementia with Lewy bodies. Journal of neurology, neurosurgery, and psychiatry, 2005, Volume: 76, Issue:9 Topics: Administration, Oral; Age Factors; Aged; Antiparkinson Agents; Basal Ganglia Diseases; Female; Humans; Levodopa; Lewy Body Disease; Male; Mental Status Schedule; Severity of Illness Index; Treatment Outcome	2005
Levodopa and swallowing reflex. Lancet (London, England), 1996, Nov-09, Volume: 348, Issue:9037 Topics: Aged; Basal Ganglia Diseases; Cerebral Infarction; Cross-Over Studies; Deglutition; Deglutition Disorders; Double-Blind Method; Humans; Levodopa; Pneumonia, Aspiration	1996
123I-IBZM binding compared with long-term clinical follow up in patients with de novo parkinsonism. Movement disorders : official journal of the Movement Disorder Society, 1998, Volume: 13, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Apomorphine; Basal Ganglia Diseases; Benzamides; Chi-Square Distribution; Disease Progression; Dopamine Agonists; Follow-Up Studies; Humans; Iodine Radioisotopes; Levodopa; Middle Aged; Parkinson Disease; Prognosis; Prospective Studies; Severity of Illness Index; Tomography, Emission-Computed, Single-Photon; Treatment Outcome	1998
Does pattern electroretinogram spatial tuning alteration in Parkinson's disease depend on motor disturbances or retinal dopaminergic loss? Electroencephalography and clinical neurophysiology, 1998, Volume: 106, Issue:4 Topics: Adult; Antiparkinson Agents; Basal Ganglia Diseases; Brain Injuries; Dopamine; Electroencephalography; Electroretinography; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Pattern Recognition, Visual; Photic Stimulation; Retina; Space Perception; Vision, Monocular	1998
The effect of L-dopa on young patients with simple schizophrenia, treated with neuroleptic drugs: a double-blind cross-over trial with Madopar and placebo. Psychopharmacologia, 1975, Oct-14, Volume: 44, Issue:1 Topics: Adult; Affect; Antipsychotic Agents; Anxiety; Basal Ganglia Diseases; Benserazide; Brief Psychiatric Rating Scale; Clinical Trials as Topic; Drug Combinations; Emotions; Humans; Hydrazines; Levodopa; Placebos; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Social Behavior	1975
Restatement and prospectives of ergot alkaloids in clinical neurology and psychiatry. Pharmacology, 1978, Volume: 16 Suppl 1 Topics: Aged; Amantadine; Basal Ganglia Diseases; Bromocriptine; Chorea; Clinical Trials as Topic; Depression; Drug Evaluation; Humans; Levodopa; Parkinson Disease; Tranquilizing Agents	1978
Hereditary motor and sensory neuropathy with treatable extrapyramidal features. Archives of neurology, 1992, Volume: 49, Issue:2 Topics: Adult; Aged; Basal Ganglia Diseases; Carbidopa; Drug Combinations; Female; Hereditary Sensory and Motor Neuropathy; Humans; Levodopa; Male; Middle Aged; Peripheral Nervous System Diseases; Placebos	1992

Other Studies

61 other study(ies) available for levodopa and Basal Ganglia Diseases

Article	Year
Neuroleptic malignant-like syndrome associated multiple system atrophy: report on three cases. BMC neurology, 2022, Feb-25, Volume: 22, Issue:1 Topics: Antipsychotic Agents; Basal Ganglia Diseases; Humans; Levodopa; Multiple System Atrophy; Neuroleptic Malignant Syndrome	2022
Levodopa-responsive parkinsonism in a patient with corticobasal degeneration and bilateral choroid plexus xanthogranulomas. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2020, Volume: 71 Topics: Aged; Antiparkinson Agents; Basal Ganglia Diseases; Choroid Plexus; Granuloma; Humans; Hydrocephalus; Levodopa; Male; Parkinsonian Disorders; Xanthomatosis	2020
Subacute corticobasal syndrome following internal carotid endarterectomy. Revue neurologique, 2018, Volume: 174, Issue:3 Topics: Aged; Basal Ganglia Diseases; Cerebral Hemorrhage; Cerebrovascular Circulation; Diffusion Magnetic Resonance Imaging; Dopamine Agents; Endarterectomy, Carotid; Hemiplegia; Humans; Hypoxia, Brain; Levodopa; Magnetic Resonance Imaging; Male; Memory Disorders; Neuropsychological Tests; Positron-Emission Tomography; Postoperative Complications; Tomography, X-Ray Computed	2018
Case 38-2017. A 20-Year-Old Woman with Seizures and Progressive Dystonia. The New England journal of medicine, 2017, Dec-14, Volume: 377, Issue:24 Topics: Basal Ganglia Diseases; Biotin; Brain; Carbidopa; Diagnosis, Differential; Drug Combinations; Dystonia; Female; Humans; Levodopa; Macula Lutea; Magnetic Resonance Imaging; Membrane Transport Proteins; Metabolism, Inborn Errors; Mutation; Optic Nerve; Seizures; Thiamine; Young Adult	2017
[An acute onset extrapyramidal, pyramidal, and cerebellar syndrome with eye movement dysfunction]. Revue neurologique, 2015, Volume: 171, Issue:12 Topics: Aged; Basal Ganglia Diseases; Cerebellar Diseases; Dopamine Agents; Humans; Levodopa; Magnetic Resonance Imaging; Male; Ocular Motility Disorders; Pyramidal Tracts; Syndrome; Treatment Outcome	2015
Persistent pain as a non-motor symptom in corticobasal syndrome. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2016, Volume: 29 Topics: Aged; Antiparkinson Agents; Basal Ganglia Diseases; Female; Humans; Levodopa; Male; Middle Aged; Pain; Retrospective Studies	2016
Subarachnoid hemorrhage and extrapyramidal symptoms: a case report. Acta bio-medica : Atenei Parmensis, 2016, 09-13, Volume: 87, Issue:2 Topics: Basal Ganglia Diseases; Humans; Hydrocephalus; Levodopa; Male; Middle Aged; Parkinson Disease; Subarachnoid Hemorrhage; Tomography, X-Ray Computed	2016
Fahr's Disease Presenting as Late-Onset Levodopa-Responsive Parkinsonism. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2017, Volume: 44, Issue:3 Topics: Aged; Antiparkinson Agents; Basal Ganglia Diseases; Calcinosis; Carbidopa; Drug Combinations; Humans; Levodopa; Male; Neurodegenerative Diseases	2017
Cavernous hemangioma: a rare cause for secondary parkinsonism: a case report. The International journal of neuroscience, 2009, Volume: 119, Issue:11 Topics: Aged; Antiparkinson Agents; Basal Ganglia Diseases; Carbidopa; Female; Globus Pallidus; Hemangioma, Cavernous, Central Nervous System; Humans; Levodopa; Magnetic Resonance Imaging; Parkinsonian Disorders; Putamen; Tomography, X-Ray Computed; Treatment Failure	2009
[Extrapyramidal symptoms due to calcinosis cerebri in a patient with unknown primary hypoparathyroidism]. Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2012, Volume: 59, Issue:1 Topics: Basal Ganglia Diseases; Brain Diseases, Metabolic; Calcinosis; Calcitriol; Calcium; Cognition Disorders; Depressive Disorder; Diagnosis, Differential; Dyslipidemias; Female; Gait Disorders, Neurologic; Gluconates; Humans; Hypoparathyroidism; Levodopa; Magnesium; Middle Aged; Syndrome	2012
[Transcient improvement of extrapyramidal syndrome after general anaesthesia]. Annales francaises d'anesthesie et de reanimation, 2012, Volume: 31, Issue:3 Topics: Aged; Anesthesia, General; Antiparkinson Agents; Basal Ganglia Diseases; Female; Humans; Levodopa; Meningioma; Neural Pathways; Parkinson Disease; Perioperative Care	2012
Striatal interaction among dopamine, glutamate and ascorbate. Neuropharmacology, 2012, Volume: 63, Issue:8 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antioxidants; Ascorbic Acid; Basal Ganglia Diseases; Chromatography, High Pressure Liquid; Dopamine; Dopamine Agents; Dopamine Antagonists; Electrochemistry; Fluorometry; Glutamic Acid; Haloperidol; Levodopa; Male; Microdialysis; Neostriatum; Rats; Rats, Sprague-Dawley	2012
Is blinking of the eyes affected in extrapyramidal disorders? An interesting observation in a patient with Wilson disease. BMJ case reports, 2012, Nov-27, Volume: 2012 Topics: Adult; Antiparkinson Agents; Basal Ganglia Diseases; Blinking; Carbidopa; Ceruloplasmin; Drug Therapy, Combination; Female; Hepatolenticular Degeneration; Humans; Levodopa; Penicillamine; Trihexyphenidyl; Zinc Sulfate	2012
Neonatal dopa-responsive extrapyramidal syndrome in twins with recessive GTPCH deficiency. Neurology, 2003, Jan-28, Volume: 60, Issue:2 Topics: Adolescent; Antiparkinson Agents; Basal Ganglia Diseases; Carbidopa; Dopamine Agents; Dystonia; Female; Follow-Up Studies; Genes, Recessive; GTP Cyclohydrolase; Homozygote; Humans; Infant, Newborn; Infant, Newborn, Diseases; Levodopa; Metabolism, Inborn Errors; Muscle Rigidity; Mutation; Reflex, Abnormal; Remission Induction; Treatment Outcome; Tremor	2003
Measurements of transcallosally mediated cortical inhibition for differentiating parkinsonian syndromes. Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:5 Topics: Aged; Antiparkinson Agents; Basal Ganglia Diseases; Corpus Callosum; Diagnosis, Differential; Electromyography; Humans; Levodopa; Magnetic Resonance Imaging; Magnetoencephalography; Middle Aged; Motor Cortex; Multiple System Atrophy; Muscle, Skeletal; Nerve Degeneration; Nerve Net; Neural Inhibition; Parkinsonian Disorders; Supranuclear Palsy, Progressive	2004
Deep brain stimulation of CM/PF of thalamus could be the new elective target for tremor in advanced Parkinson's Disease? Parkinsonism & related disorders, 2008, Volume: 14, Issue:6 Topics: Adult; Antiparkinson Agents; Basal Ganglia Diseases; Deep Brain Stimulation; Electrodes, Implanted; Electromyography; Female; Humans; Intralaminar Thalamic Nuclei; Levodopa; Male; Middle Aged; Neurosurgical Procedures; Parkinson Disease; Tremor	2008
The role of anticholinergic drugs in extra-pyramidal syndromes. Neuropharmacology, 1981, Volume: 20, Issue:12B Topics: Antipsychotic Agents; Basal Ganglia Diseases; Dopamine; Dyskinesia, Drug-Induced; Humans; Levodopa; Movement Disorders; Parasympatholytics; Parkinson Disease	1981
Basal ganglia disease. Lancet (London, England), 1982, Nov-20, Volume: 2, Issue:8308 Topics: Basal Ganglia Diseases; Dopamine; Humans; Huntington Disease; Levodopa; Models, Biological; Movement Disorders; Neurotransmitter Agents; Parasympatholytics; Parkinson Disease	1982
Neuroleptic malignant syndrome and neuroleptic-induced catatonia: differential diagnosis and treatment. International journal of psychiatry in medicine, 1984, Volume: 14, Issue:1 Topics: Aged; Antipsychotic Agents; Basal Ganglia Diseases; Carbidopa; Catatonia; Diagnosis, Differential; Female; Haloperidol; Humans; Levodopa; Syndrome; Trihexyphenidyl	1984
Fatal hyperpyrexia after withdrawal of levodopa. Neurology, 1984, Volume: 34, Issue:2 Topics: Basal Ganglia Diseases; Dyskinesia, Drug-Induced; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Substance Withdrawal Syndrome	1984
Manganese and extrapyramidal disorders (a critical review and tribute to Dr. George C. Cotzias). Neurotoxicology, 1984,Spring, Volume: 5, Issue:1 Topics: Animals; Basal Ganglia; Basal Ganglia Diseases; Brain Chemistry; Catecholamines; Disease Models, Animal; Humans; Levodopa; Manganese; Manganese Poisoning; Melanins; Melanocyte-Stimulating Hormones; Parkinson Disease; Substantia Nigra	1984
Levodopa induced chorea in Meige syndrome. Journal of neurology, neurosurgery, and psychiatry, 1983, Volume: 46, Issue:3 Topics: Adult; Basal Ganglia Diseases; Chorea; Dose-Response Relationship, Drug; Female; Humans; Levodopa	1983
Management of the extrapyramidal manifestations of phenylketonuria with L-dopa. Archives of disease in childhood, 1983, Volume: 58, Issue:6 Topics: Basal Ganglia Diseases; Female; Follow-Up Studies; Humans; Infant; Levodopa; Phenylketonurias	1983
[Current problems in the diagnosis and treatment of hereditary diseases of the nervous system]. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1982, Volume: 82, Issue:3 Topics: Basal Ganglia Diseases; Catecholamines; Dystonia Musculorum Deformans; Female; Genetic Carrier Screening; Hepatolenticular Degeneration; Humans; Levodopa; Nervous System Diseases; Polymorphism, Genetic; Pregnancy; Prenatal Diagnosis	1982
Progressive supranuclear palsy, computed tomography, and response to antiparkinsonian drugs. Neurology, 1981, Volume: 31, Issue:4 Topics: Aged; Atrophy; Basal Ganglia Diseases; Benztropine; Cerebellum; Eye Movements; Humans; Levodopa; Male; Mesencephalon; Middle Aged; Parkinson Disease; Speech; Tomography, X-Ray Computed; Tropanes	1981
A perplexing case of juvenile extrapyramidal disease. Italian journal of neurological sciences, 1981, Volume: 2, Issue:2 Topics: Adolescent; Atrophy; Basal Ganglia Diseases; Bromocriptine; Electroencephalography; Female; Globus Pallidus; Humans; Levodopa; Parkinson Disease, Secondary; Tomography, X-Ray Computed	1981
Familial levodopa-responsive parkinsonian-pyramidal syndrome. Movement disorders : official journal of the Movement Disorder Society, 1994, Volume: 9, Issue:6 Topics: Adolescent; Adult; Basal Ganglia Diseases; Carbidopa; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Levodopa; Male; Neurologic Examination; Parkinson Disease; Pedigree	1994
Rest tremor and extrapyramidal symptoms after midbrain haemorrhage: clinical and 18F-dopa PET evaluation. Journal of neurology, neurosurgery, and psychiatry, 1994, Volume: 57, Issue:8 Topics: Adult; Basal Ganglia Diseases; Dihydroxyphenylalanine; Electromyography; Fluorine Radioisotopes; Humans; Intracranial Arteriovenous Malformations; Levodopa; Male; Mesencephalon; Posture; Rest; Rupture, Spontaneous; Subarachnoid Hemorrhage; Thalamus; Tomography, Emission-Computed; Tremor	1994
Levodopa-responsive parkinsonism associated with basal ganglia calcification and primary hypoparathyroidism. Movement disorders : official journal of the Movement Disorder Society, 1993, Volume: 8, Issue:3 Topics: Adult; Basal Ganglia; Basal Ganglia Diseases; Brain; Calcinosis; Calcium; Humans; Hypoparathyroidism; Levodopa; Magnetic Resonance Imaging; Male; Neurologic Examination; Parkinson Disease; Tomography, X-Ray Computed; Vitamin D	1993
Whole blood monoamine oxidase activity in Parkinson's disease and multiple system atrophy patients. Journal of the neurological sciences, 1993, Volume: 117, Issue:1-2 Topics: Aged; Aged, 80 and over; Atrophy; Basal Ganglia Diseases; Blood Platelets; Brain; Dopamine; Enzyme Induction; Female; Humans; Levodopa; Male; Middle Aged; Monoamine Oxidase; Olivopontocerebellar Atrophies; Parkinson Disease; Shy-Drager Syndrome	1993
Extrapyramidal syndrome responsive to dopaminergic treatment following recovery from central pontine myelinolysis. European neurology, 1993, Volume: 33, Issue:1 Topics: Basal Ganglia Diseases; Biperiden; Carbidopa; Chlorthalidone; Coma; Drug Therapy, Combination; Female; Humans; Hypertension; Hyponatremia; Levodopa; Lisuride; Middle Aged; Neurologic Examination; Parkinson Disease, Secondary; Pons; Quadriplegia; Saline Solution, Hypertonic; Tomography, X-Ray Computed	1993
Serotonin and Parkinson's disease. The American journal of psychiatry, 1993, Volume: 150, Issue:5 Topics: Basal Ganglia Diseases; Depressive Disorder; Dopamine; Drug Therapy, Combination; Fluoxetine; Humans; Levodopa; Parkinson Disease; Serotonin; Tryptophan	1993
Executive function in Parkinson's disease: set-shifting or set-maintenance? Journal of clinical and experimental neuropsychology, 1993, Volume: 15, Issue:2 Topics: Aged; Attention; Basal Ganglia Diseases; Humans; Levodopa; Mental Processes; Neuropsychological Tests; Parkinson Disease; Regression Analysis	1993
Parkinsonian manifestations in a patient with homocystinuria. Journal of child neurology, 1996, Volume: 11, Issue:3 Topics: Antiparkinson Agents; Basal Ganglia Diseases; Child; Homocystinuria; Humans; Levodopa; Magnetic Resonance Imaging; Male; Parkinson Disease, Secondary	1996
N30 wave amplitude of somatosensory evoked potentials from median nerve in Parkinson's disease: a pharmacological study. Journal of neural transmission. Supplementum, 1995, Volume: 45 Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Apomorphine; Basal Ganglia Diseases; Case-Control Studies; Dopamine Agonists; Evoked Potentials, Somatosensory; Humans; Levodopa; Median Nerve; Middle Aged; Parkinson Disease; Psychotic Disorders; Reaction Time; Reference Values	1995
[The prolactin and thyrotropic hormone content of the blood plasma in neostriatal dysfunction]. Fiziologicheskii zhurnal imeni I.M. Sechenova, 1995, Volume: 81, Issue:12 Topics: Basal Ganglia Diseases; Carbidopa; Dopamine Agonists; Dopamine Antagonists; Drug Combinations; Haloperidol; Humans; Immunoenzyme Techniques; Levodopa; Neostriatum; Prolactin; Thyrotropin; Time Factors	1995
Deterioration of parkinsonian symptoms following treatment of dopaminergic hallucinosis with olanzapine. European psychiatry : the journal of the Association of European Psychiatrists, 1999, Volume: 14, Issue:6 Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Clozapine; Drug Therapy, Combination; Hallucinations; Humans; Levodopa; Male; Olanzapine; Paranoid Disorders; Parkinson Disease; Piperidines; Pirenzepine; Selegiline; Severity of Illness Index	1999
Levodopa-induced dyskinesias in autopsy-proven cortical-basal ganglionic degeneration. Movement disorders : official journal of the Movement Disorder Society, 2000, Volume: 15, Issue:2 Topics: Aged; Antiparkinson Agents; Basal Ganglia; Basal Ganglia Diseases; Cerebral Cortex; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Neurodegenerative Diseases; Neurologic Examination; Parkinson Disease	2000
Propionic acidaemia with basal ganglia stroke: treatment of acute extrapyramidal symptoms with L-DOPA. Journal of inherited metabolic disease, 2001, Volume: 24, Issue:5 Topics: Adolescent; Basal Ganglia Diseases; Humans; Levodopa; Magnetic Resonance Imaging; Male; Propionates; Stroke	2001
[Potential therapeutic activity of GABA-mimetic drugs in neuropsychiatry]. Schweizer Archiv fur Neurologie, Neurochirurgie und Psychiatrie = Archives suisses de neurologie, neurochirurgie et de psychiatrie, 1979, Volume: 125, Issue:2 Topics: 4-Aminobutyrate Transaminase; Basal Ganglia Diseases; Bicuculline; Dopamine; Dyskinesia, Drug-Induced; Epilepsy; Extrapyramidal Tracts; gamma-Aminobutyric Acid; Humans; Huntington Disease; Levodopa; Limbic System; Neural Pathways; Neurons; Neurotransmitter Agents; Parkinson Disease; Psychopharmacology	1979
Letter: Extrapyramidal dementia and levodopa. Lancet (London, England), 1975, Apr-05, Volume: 1, Issue:7910 Topics: Aged; Basal Ganglia Diseases; Dementia; Female; Humans; Levodopa; Male; Parkinson Disease	1975
[Clinical picture and treatment of Parkinson-like syndromes of hereditary etiology]. Klinicheskaia meditsina, 1978, Volume: 56, Issue:9 Topics: Adolescent; Adult; Basal Ganglia Diseases; Child; Diagnosis, Differential; Female; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Pantothenate Kinase-Associated Neurodegeneration; Parkinson Disease	1978
Levo-dopa in patients with post-encephalitic mental and extrapyramidal disorders. Indian journal of pediatrics, 1975, Volume: 42, Issue:328 Topics: Basal Ganglia Diseases; Child; Child, Preschool; Encephalitis, Japanese; Female; Humans; Levodopa; Male; Mental Disorders	1975
Combination therapy of extrapyramidal disease with trihexyphenidyl and L-dopa: an electromyographic study with specific reference to tremor. The Journal of international medical research, 1979, Volume: 7, Issue:1 Topics: Aged; Basal Ganglia Diseases; Drug Therapy, Combination; Electromyography; Female; Humans; Levodopa; Middle Aged; Parkinson Disease; Torticollis; Tremor; Trihexyphenidyl	1979
[Risks in the treatment of parkinsonism with l-dopa and a dopa decarboxylase inhibitor]. Die Medizinische Welt, 1979, Nov-16, Volume: 30, Issue:46 Topics: Basal Ganglia Diseases; Blood-Brain Barrier; Dopa Decarboxylase; Enzyme Inhibitors; Humans; Levodopa; Parkinson Disease	1979
Respiratory dyskinesias: extrapyramidal dysfunction and dyspnea. Annals of internal medicine, 1978, Volume: 88, Issue:3 Topics: Adult; Basal Ganglia Diseases; Central Nervous System; Dyskinesia, Drug-Induced; Dyspnea; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Receptors, Dopamine; Tranquilizing Agents	1978
[Idiopathic dystonia with oppositional movement and flapping-like tremor, and the therapeutic effect of levodopa]. Rinsho shinkeigaku = Clinical neurology, 1976, Volume: 16, Issue:11-3ENA-NA Topics: Adult; Basal Ganglia Diseases; Humans; Levodopa; Male	1976
[Comparison between EEG-finding and clinical picture in patients with Parkinsonism under L-dopa]. Wiener medizinische Wochenschrift (1946), 1975, Feb-14, Volume: 125, Issue:7-8 Topics: Basal Ganglia Diseases; Brain; Electroencephalography; Humans; Levodopa; Parkinson Disease	1975
[Current medical treatment in the disorders of the extrapyramidal nervous system]. La Clinica terapeutica, 1975, Aug-31, Volume: 74, Issue:4 Topics: Basal Ganglia Diseases; Carboxy-Lyases; Humans; Levodopa; Parkinson Disease	1975
Inhibition of circling behavior by neuroleptic drugs in mice with unilateral 6-hydroxydopamine lesions of the striatum. Psychopharmacologia, 1975, Dec-31, Volume: 45, Issue:2 Topics: Animals; Apomorphine; Basal Ganglia Diseases; Behavior; Biogenic Amines; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Chlorpromazine; Clozapine; Corpus Striatum; Dextroamphetamine; Diazepam; Dopamine; Haloperidol; Humans; Hydroxydopamines; Levodopa; Male; Metoclopramide; Mice; Motor Activity; Pentobarbital; Phenoxybenzamine; Pimozide; Promethazine; Stereotyped Behavior; Tranquilizing Agents	1975
Neuroleptics and the corpus striatum: clinical implications. Diseases of the nervous system, 1976, Volume: 37, Issue:4 Topics: Acetylcholine; Basal Ganglia Diseases; Benztropine; Corpus Striatum; Dopamine; Fluphenazine; Haloperidol; Humans; Levodopa; Models, Neurological; Movement Disorders; Parkinson Disease; Reserpine; Schizophrenia; Tranquilizing Agents; Trihexyphenidyl	1976
Autonomic involvement in extrapyramidal and cerebellar disorders. Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 1991, Volume: 1, Issue:2 Topics: Adult; Aged; Antiparkinson Agents; Autonomic Nervous System Diseases; Basal Ganglia Diseases; Cerebellar Diseases; Cognition Disorders; Female; Heart Rate; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Reflex; Shy-Drager Syndrome; Supranuclear Palsy, Progressive; Valsalva Maneuver	1991
Biochemical and neurophysiological investigations in two forms of Segawa's disease. Neuropediatrics, 1990, Volume: 21, Issue:1 Topics: Adolescent; Basal Ganglia Diseases; Benserazide; Diagnosis, Differential; Dystonia; Evoked Potentials; Female; Humans; Levodopa; Male; Syndrome; Tyrosine 3-Monooxygenase	1990
Manganese neurotoxicity: effects of L-DOPA and pargyline treatments. Brain research, 1986, Mar-05, Volume: 367, Issue:1-2 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Basal Ganglia Diseases; Corpus Striatum; Dopamine; Drug Synergism; Hydroxyindoleacetic Acid; Levodopa; Male; Manganese Poisoning; Pargyline; Parkinson Disease; Rats; Serotonin	1986
Facial dystonia: clinical features, prognosis and pharmacology in 31 patients. Italian journal of neurological sciences, 1989, Volume: 10, Issue:6 Topics: Adult; Aged; Basal Ganglia Diseases; Botulinum Toxins; Drug Combinations; Female; Haloperidol; Humans; Levodopa; Male; Meige Syndrome; Middle Aged; Phenethylamines; Prognosis; Selegiline	1989
[Metrizamide encephalopathy in a child with hydrocephalus--effects of L-threo-DOPS on persistent disturbance of consciousness and L-dopa on extrapyramidal symptoms]. No to shinkei = Brain and nerve, 1988, Volume: 40, Issue:11 Topics: Basal Ganglia Diseases; Brain; Brain Diseases; Child; Cognition Disorders; Consciousness Disorders; Droxidopa; Electroencephalography; Extravasation of Diagnostic and Therapeutic Materials; Female; Humans; Hydrocephalus; Levodopa; Metrizamide; Serine; Tomography, X-Ray Computed	1988
Carbidopa-levodopa therapy for movement disorders. Archives of physical medicine and rehabilitation, 1987, Volume: 68, Issue:10 Topics: Basal Ganglia Diseases; Carbidopa; Craniocerebral Trauma; Drug Therapy, Combination; Humans; Levodopa; Movement Disorders	1987
[Clinical modification of cerebral palsy of the extrapyramidal type by L-dopa (Dopaflex)--longitudinal pilot study]. Padiatrie und Grenzgebiete, 1986, Volume: 25, Issue:5 Topics: Basal Ganglia Diseases; Cerebral Palsy; Child; Female; Humans; Levodopa; Longitudinal Studies; Male; Muscle Tonus; Pilot Projects	1986
[Current status of conservative therapy of extrapyramidal movement disorders in childhood and adolescence]. Wiener medizinische Wochenschrift. Supplement, 1985, Volume: 88 Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Autogenic Training; Basal Ganglia; Basal Ganglia Diseases; Brain Damage, Chronic; Child; Child, Preschool; Education, Special; Electroencephalography; Female; Follow-Up Studies; Humans; Levodopa; Male; Muscle Hypertonia; Parkinson Disease, Secondary; Psychotropic Drugs; Risk; Tic Disorders	1985
Hemidystonia: a report of 22 patients and a review of the literature. Journal of neurology, neurosurgery, and psychiatry, 1985, Volume: 48, Issue:7 Topics: Adolescent; Adult; Aged; Basal Ganglia Diseases; Brain Damage, Chronic; Brain Diseases; Brain Injuries; Carbidopa; Child; Child, Preschool; Dominance, Cerebral; Dystonia; Dystonia Musculorum Deformans; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Tomography, X-Ray Computed; Trihexyphenidyl	1985
Mechanisms involved in the control of extrapyramidal dysfunctions and in striatal dopamine synthesis. Advances in neurology, 1974, Volume: 5 Topics: Animals; Antiparkinson Agents; Apomorphine; Basal Ganglia Diseases; Bucladesine; Carbidopa; Carbon Radioisotopes; Corpus Striatum; Depression, Chemical; Dopamine; Drug Therapy, Combination; Haloperidol; Haplorhini; Levodopa; Receptors, Drug; Stimulation, Chemical; Tremor	1974